Authors
Latest:
Pharmacists in ACOs Part 3: Chronic Care Management, Chronic Disease State Management, and Transition of CareAfter discussing the Basics of Accountable Care Organizations and Medication Therapy Management and Annual Wellness Visit services, the third and last section of the Pharmacists in ACOs series will focus on 3 more integration strategies for pharmacists within the ACO setting, including chronic care management, chronic disease state management, and transitions of care.
Latest:
Protein S DeficiencyProtein S deficiency is a type of inherited thrombophilia associated with increased risk of venous thromboembolism.
Latest:
Alpha-Gal (Mammalian Meat) Allergy: Implications for PharmacistsAlpha-gal, a mammalian oligosaccharide, has recently been implicated in delayed anaphylaxis reactions to mammalian meat.
Latest:
Second Look at Utilization of a Closed-System Transfer Device (PhaSeal)The Phaseal closed-system transfer device can extend the beyond-use date of pharmaceuticals, thereby reducing waste.
Latest:
caseSTUDIESLatest:
Head Lice Treatment: Perspective for PharmacistsAn estimated 6 to 12 million individuals in the United States develop head lice each year, with most cases occurring in children ages 3 to 11.
Latest:
Heart Failure: Implications for Quality Improvement and Hands-on TrainingThis Continuing Education activity is supported by an educational grant from Novartis Pharmaceuticals Corporation..
Latest:
Do Units and Costs of Comparable Insulins Differ by Manufacturer?Patient characteristics and product mix play an important role in determining the overall use and costs of comparable insulins across different manufacturers.
Latest:
CASE STUDIESLatest:
Summary of Current SARS-CoV-2 Vaccine TrialsMany clinical trials are underway in a race to develop a safe and effective vaccine against severe acute respiratory SARS-CoV-2, the virus that causes COVID-19.
Latest:
Improving the Patient Journey Through Health System Partnerships Enhances CareHealth system specialty pharmacies are creating a more integrated care structure for complex patients on specialty drug regimens.
Latest:
Diabetes Quality Measurement: A Primer for PharmacistsThe continuing education article reviews diabetes quality improvement efforts and the potential for expanding the role of pharmacists as clinical care providers.
Latest:
Is PBM Transparency an Answer to Controlling Rising Drug Costs?With continued increases in the US drug spend, the evolution of fully transparent PBM programs has introduced an alternative approach to traditional PBM structures aimed at enhanced utilization and cost control.
Latest:
Cost and Utilization Outcomes Associated With a Dosage Consolidation and Quantity Limits ProgramDose consolidation and quantity limit initiatives decreased utilization and cost outcomes for select mental health drugs in a fee-for-service Medicaid environment.
Latest:
Copayment Level and Drug Switching: Findings for Type 2 DiabetesAmong insured patients with type 2 diabetes, copayments and glycosylated hemoglobin values were associated with increased rates of drug switching.
Latest:
Chemotherapy and ObesityWhen giving antineoplastics to obese and morbidly obese patients, clinicians must be careful not to under- or overdose.
Latest:
What Are the Implications of the MERINO Trial?Is piperacillin/tazobactam an effective carbapenem alternative to treat bloodstream infections caused by ESBL-producing enterobacteriaceae.
Latest:
Review of Outcomes Associated With Formulary Restrictions: Focus on Step TherapyAs healthcare spending continues to rise, more employers, managed care organizations, and pharmacy benefit managers are implementing novel pharmacy benefit designs and formulary management policies to control drug spending.
Latest:
Patient-Centered Care: The Case for Site Expansion to Include Health System Specialty PharmacyHealth systems and manufacturers need to work together to obtain inclusion for health system specialty pharmacies so that patients can fill their prescriptions within a coordinated care ecosystem.
Latest:
Pharmacy Technicians Contribute to Positive Outcomes for Patients Using Opioids by Avoiding StigmaPerhaps no other health care worker has been exposed to the opioid epidemic more frequently than pharmacy technicians and pharmacists.
Latest:
Hepatitis C Management: How Payers, Providers, and Pharmacies Can Work Together to Stem CostsNew models of collaboration can guide providers in optimizing care for patients with HCV.
Latest:
Copayment Level and Drug Switching: Findings for Type 2 DiabetesAmong insured patients with type 2 diabetes, copayments and glycosylated hemoglobin values were associated with increased rates of drug switching.
Latest:
Justice Department Places Increased Scrutiny On Pharmacies, PharmacistsFederal prosecutors are increasingly turning their attention to pharmacies and pharmacists. In this article, we detail some of the recent enforcement efforts, as well as outline some proactive strategies for compliance.
Latest:
Comparing Direct Medical Costs of OnabotulinumtoxinA With Other Common Overactive Bladder InterventionsThis cost analysis demonstrated that onabotulinumtoxinA is one of the least-costly treatment options for inadequately managed overactive bladder syndrome.
Latest:
Prostate Cancer: Facts, Causes, and TreatmentsProstate cancer is the leading cancer in men, with about 1 in 8 developing it in his lifetime.
Latest:
Lessons Learned: How Health-System Pharmacy Technicians Are Tackling COVID-19The California Board of Pharmacy has authorized multiple waivers of specific provisions of pharmacy law, several of which have had major implications for pharmacy technicians and their scope of practice.
